Cardiovascular Consultants of Nevada Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2012
NCT01558830
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now